lipoxin a4 has been researched along with Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bäck, M; Hedin, U; Laguna-Fernandez, A; Perretti, M; Petri, MH; Tseng, CN | 1 |
| Dong, L; Liu, B; Wu, HJ; Wu, SH | 1 |
2 other study(ies) available for lipoxin a4 and Hyperplasia
| Article | Year |
|---|---|
Aspirin-triggered 15-epi-lipoxin A₄ signals through FPR2/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Hyperplasia; Lipoxins; Mice; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Receptors, Formyl Peptide; Tunica Intima | 2015 |
NF-kappaB is involved in inhibition of lipoxin A4 on dermal inflammation and hyperplasia induced by mezerein.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carcinogens; Cell Line; Cytokines; Dermis; Disease Models, Animal; Diterpenes; Female; Humans; Hyperplasia; Inflammation; Keratinocytes; Lipoxins; Mice; Mice, Inbred Strains; NF-kappa B | 2010 |